Growth factor helps diagnose ectopic pregnancy:
This article was originally published in Clinica
Vascular endothelial growth factor (VEGF) could be used to diagnose ectopic pregnancy, according to a study carried out by researchers at Tel Aviv Sourasky Medical Centre in Israel. Progesterone and human chorionic gonadotrophin have both been used for this purpose, but neither is highly specific for ectopic pregnancy. Elevated VEGF levels had a sensitivity of 60% and a specificity of 90% for distinguishing extrauterine from interuterine pregnancies, the researchers report in Fertility and Sterility (December). Combining the VEGF measurement with serum progesterone levels enhanced the test's specificity to 95%.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.